DNA Testing Market to Make Great Impact in Near Future by 2032

The report published by The Brainy Insights shows that the DNA testing market is expected to grow from USD 10​.0​ billion in 2022 to USD 23.04 billion by 2030, at a CAGR of 11​.0​% during the forecast period 2022-2030. North America emerged as the largest market for the global DNA testing market, with a 39% market revenue share in 2022. The DNA testing market in the region has been growing due to the increasing investment in research and development activities by the government and prominent market players. The North American DNA testing market is expanding due to the presence of advanced healthcare infrastructure, an increase in the frequency of DNA disorders, and supportive government activities regarding DNA diagnosis and its use in in-vitro fertilization. The North American region also has an improved healthcare infrastructure and better investment in improving healthcare facilities.

Get an Inside Scoop of Study, Request now for Sample Study @ https://www.thebrainyinsights.com/enquiry/sample-request/13017

DNA Testing Market Size By Technology (PCR Based, Microarray Based, In-situ Hybridization, and NGS DNA Diagnosis), By Application (Pre-natal DNA Carrier Screening, Newborn DNA Screening, Pre-implantation Diagnosis, Oncology Diagnostics & Histopathology, Infectious Disease Diagnostics, Identify Diagnostics & Forensic, Pharmacogenomics Diagnostic Testing, and Others), Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Leading companies in the industry include ​​​​Agilent Technologies Inc., ​Abbott Laboratories, ​Illumina Inc., ​ ​Bio-Rad Laboratories, ​Beckman Coulter Inc., ​Thermo Fisher Scientific, ​ ​Cepheid Inc., ​Applied Biosystems Group, ​Transgenomic Inc., and Siemens Healthcare offer more significant opportunities and continuously focus on new product developments and venture capital investments to obtain market share.

Check Index of Research Study @ https://www.thebrainyinsights.com/report/dna-testing-market-13017

The technology segment is divided into PCR Based, Microarray Based, In-situ Hybridization, and NGS DNA Diagnosis. The PCR-based segment dominated, with a market share of around 35% in 2022. The segment's growth is driven by the increasing preference rate and greater availability of PCR-based DNA testing kits and reagent kits. The application segment is divided into Pre-natal DNA Carrier Screening, Newborn DNA Screening, Pre-implantation Diagnosis, Oncology Diagnostics & Histopathology, Infectious Disease Diagnostics, Identify Diagnostics & Forensic, Pharmacogenomics Diagnostic Testing, and Others. Over the forecast period, the infectious disease diagnostics segment is expected to grow at the fastest CAGR of 13%. The growing number of human infections increases the demand for infectious disease diagnostics through DNA testing, propelling the segment's growth.

The market's growth is expected to be boosted by the introduction of novel technologies for genome profiling. In addition, it is likely that rising rates of infectious diseases and chronic oncologies, which depend on DNA prototyping for diagnosis and treatment using personalized medicine, will significantly increase the demand for DNA testing-based research, driving industrial growth during the forecast period. However, the high cost of DNA testing is expected to hinder the market's growth. DNA testing is regulated by the FDA in various ways, with some requiring regulatory frameworks as intricate as those for Class III medical devices. The stringent government regulations challenge the market's growth.

Enquire for customization in Report @ https://www.thebrainyinsights.com/enquiry/request-customization/13017

About The Brainy Insights:
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirements whether they are looking to expand or planning to launch a new product in the global market.

Contact Us
Avinash D
Head of Business Development
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: www.thebrainyinsights.com

This release was published on openPR.